1
Views
0
CrossRef citations to date
0
Altmetric
Gene Expression

Differential Modulation of Plasminogen Activator Gene Expression by Oncogene-Encoded Protein Tyrosine Kinases

, , &
Pages 5888-5897 | Received 06 Apr 1993, Accepted 03 Jun 1993, Published online: 31 Mar 2023

REFERENCES

  • Angel, P., Μ. Imagawa, R. Chiu, B. Stein, R. J. Imbra, H. J. Rahmsdorf, C. Jonat, P. Herrlich, and Μ. Karin. 1987. Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor. Cell 49:729–739.
  • Barker, K., and H. Hanafusa. 1990. Expression of 9E3 mRNA is associated with mitogenicity, phosphorylation, and morphological alteration in chicken embryo fibroblasts. Mol. Cell. Biol. 10:3813–3817.
  • Bedard, P.-A∙, D. Alcorta, D. L. Simmons, K∙-C. Luk, and R. L. Erikson. 1987. Constitutive expression of a gene encoding a polypeptide homologous to biologically active human platelet protein in Rous sarcoma virus-transformed fibroblasts. Proc. Natl. Acad. Sci. USA 84:6715–6719.
  • Bell, S. Μ., R. W. Brackenbury, N. D. Leslie, and J. L. Degen. 1990. Plasminogen activator gene expression is induced by the src oncogene product and tumor promoters. J. Biol. Chem. 265:1333–1338.
  • Birchenall-Roberts, Μ. C., F. W. Ruscetti, J. Kasper, H. Lee, R. Friedman, A. Geiser, Μ. B. Sporn, A. B. Roberts, and S. Kim. 1990. Transcriptional regulation of the transforming growth factor βl promoter by v-src gene products is mediated through the AP-I complex. Mol. Cell. Biol. 10:4978–4983.
  • Blobel, G. A., and H. Hanafusa. 1991. The v-src inducible gene 9E3∕CEF4 is regulated by both its promoter upstream sequence and its 3’ untranslated region. Proc. Natl. Acad. Sci. USA 88:1162–1166.
  • Brott, B. K., S. Decker, Μ. O’Brien, and R. Jove. 1991. Molecular features of the viral and cellular src kinases involved in interactions with the GTPase-activating protein. Mol. Cell. Biol. 11:5059–5067.
  • Brott, B. K., S. Decker, J. Shafer, J. B. Gibbs, and R. Jove. 1991. GTPase activating protein (GAP) interactions with the viral and cellular src kinases. Proc. Natl. Acad. Sci. USA 88:755–759.
  • Brugge, J., W. Yonemoto, and D. Darrow. 1983. Interaction between the Rous sarcoma virus transforming protein and two cellular phosphoproteins: analysis of the turnover and distribution of this complex. Mol. Cell. Biol. 3:9–19.
  • Buss, J. E., Μ. P. Kamps, K. Gould, and B. Μ. Sefton. 1986. The absence of myristic acid decreases membrane binding of ρ60src but does not affect tyrosine protein kinase activity. J. Virol. 58:468–474.
  • Cantley, L. C., K. R. Auger, C. Carpenter, B. Duckworth, A. Graziani, R. Kapeller, and S. Soltoff. 1991. Oncogenes and signal transduction. Cell 64:281–302.
  • Carpenter, G. 1992. Receptor tyrosine kinase substrates: src homolog domains and signal transduction. FASEB J. 6:3283–3289.
  • Collett, Μ. S., E. Erikson, and R. L. Erikson. 1979. Structural analysis of the avian sarcoma virus transforming protein: sites of phosphorylation. J. Virol. 29:770–781.
  • Colmenares, C., and E. Stavnezer. 1989. The ski oncogene induces muscle differentiation in quail embryo cells. Cell 59:293–303.
  • Courtneidge, S. A., and J. Μ. Bishop. 1982. Transit of pp60v-src to the plasma membrane. Proc. Natl. Acad. Sci. USA 79:7117–7121.
  • Cross, F. R., E. A. Garber, and H. Hanafusa. 1985. N-terminal deletions in Rous sarcoma virus p60src: effects on tyrosine kinase and biological activities and on recombination in tissue culture with the cellular src gene. Mol. Cell. Biol. 5:2789–2795.
  • Cross, F. R., and H. Hanafiisa. 1983. Local mutagenesis of Rous sarcoma virus: the major sites of tyrosine and serine phosphorylation of p60src are dispensible for transformation. Cell 34:597–607.
  • Danø, K., P. A. Andreasen, J. Grøndahl-Hansen, P. Kristensen, L. S. Nielsen, and L. Skriver. 1985. Plasminogen activators, tissue degradation, and cancer. Adv. Cancer Res. 44:139–266.
  • DeClue, J. E., K. Zhang, P. Redford, W. C. Vass, and D. R. Lowy. 1991. Suppression of src transformation by overexpression of full-length GTPase-activating protein (GAP) or of the GAP C terminus. Mol. Cell. Biol. 11:2819–2825.
  • Degen, J. L., R. D. Estensen, Y. Nagamine, and E. Reich. 1985. Induction and desensitization of plasminogen activator gene expression by tumor promoters. J. Biol. Chem. 260:12426–12433.
  • Eisenbach, L., S. Segal, and Μ. Feldman. 1985. Proteolytic enzymes in tumor metastasis. I. Plasminogen activator in clones of lewis lung carcinoma and TlO sarcoma. JNCI 74:77–85.
  • Fairbairn, S., R. Gilbert, G. Ojakian, R. Schwimmer, and J. P. Quigley. 1985. The extracellular matrix of normal chick embryo fibroblasts: its effect on the transformed chick fibroblasts and its proteolytic degradation by the transformants. J. Cell Biol. 101:1790–1798.
  • Feinberg, A. P., and B. Vogelstein. 1983. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem. 132:6–13.
  • Feldman, R. A., L.-H. Wang, H. Hanafusa, and P. C. Balduzzi. 1982. Avian sarcoma virus UR2 encodes a transforming protein which is associated with a unique protein kinase activity. J. Virol. 42:228–236.
  • Fujii, Μ., D. Shalloway, and I. Μ. Verma. 1989. Gene regulation by tyrosine kinases: src protein activates various promoters, including c-fos. Mol. Cell. Biol. 9:2493–2499.
  • Fukui, Y., and H. Hanafusa. 1989. Phosphatidylinositol kinase activity associates with viral p60src protein. Mol. Cell. Biol. 9:1651–1658.
  • Garber, E. A., J. E. Krueger, H. Hanafusa, and A. R. Goldberg. 1983. Temperature-sensitive membrane association of pp60src in tsNY-68 infected cells correlates with increased tyrosine phosphorylation of membrane-associated proteins. Virology 126:73–86.
  • Gibbs, J. B., Μ. S. Marshall, E. Μ. Scolnick, R. A. F Dixon, and U. S. Vogel. 1990. Modulation of guanine nucleotides bound to ras in NIH 3T3 cells by oncogenes, growth factors, and the GTPase activating protein (GAP). J. Biol. Chem. 265:20437–20442.
  • Gogusev, J., B. Teutsch, Μ. T. Morin, F. Mongiat, F. Haguenau, G. Suskind, and G. F. Rabotti. 1988. Inhibition of HLA class I antigen and mRNA expression induced by Rous sarcoma virus in transformed human fibroblasts. Proc. Natl. Acad. Sci. USA 85:203–207.
  • Goldfarb, R. H., and J. P. Quigley. 1978. Synergistic effect of tumor virus transformation and tumor promoter treatment on the production of plasminogen activator by chick embryo fibroblasts. Cancer Res. 38:4601–4609.
  • Gould, K. L., J. R. Woodgett, J. A. Cooper, J. E. Buss, D. Shalloway, and T. Hunter. 1985. Protein kinase C phosphorylates pp60src at a novel site. Cell 42:849–857.
  • Graham, F. L., and A. J. van der Eb. 1973. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52:456–457.
  • Groudine, Μ., and H. Weintraub. 1975. Rous sarcoma virus activates embryonic globin genes in chicken fibroblasts. Proc. Natl. Acad. Sci. USA 72:4464–4468.
  • Groudine, Μ., and H. Weintraub. 1980. Activation of cellular genes by avian RNA tumor viruses. Proc. Natl. Acad. Sci. USA 77:5351–5354.
  • Hendricks, M., and H. Weintraub. 1984. Multiple tropomyosin polypeptides in chicken embryo fibroblasts: differential repression of transcription by Rous sarcoma virus transformation. Mol. Cell. Biol. 4:1823–1833.
  • Hirayoshi, K., H. Kudo, H. Takechi, A. Nakai, A. Iwamatsu, K. Μ. Yamada, and K. Nagata. 1991. HSP47: a tissue-specific, transformation-sensitive, collagen-binding heat shock protein of chicken embryo fibroblasts. Mol. Cell. Biol. 11:4036–4044.
  • Hughes, S., J. J. Greenhouse, C. J. Petropoulos, and P. Sutrave. 1987. Adaptor plasmids simplify the insertion of foreign DNA into helper-independent retroviral vectors. J. Virol. 61:3004–3012.
  • Ishizaki, R., A. J. Langlois, J. Chabot, and J. W. Beard. 1971. Component of strain MC29 avian leukosis virus with the property of defectiveness. J. Virol. 8:821–827.
  • Jones, S. W., and K.-C. Luk. 1988. Isolation of a chicken thioredoxin cDNA clone. J. Biol. Chem. 263:9607–9611.
  • Kamps, Μ. P., J. E. Buss, and B. Μ. Sefton. 1985. Mutation of NH2-terminal glycine of p60src prevents both myristoylation and morphological transformation. Proc. Natl. Acad. Sci. USA 82:4625–4628.
  • Kamps, Μ. P., J. E. Buss, and B. Μ. Sefton. 1986. Rous sarcoma virus transforming protein lacking myristic acid phosphorylates known polypeptide substrates without inducing transformation. Cell 45:105–112.
  • Kawai, S., Μ. Yoshida, K. Segawa, H. Sugiyama, R. Ishizaki, and K. Toyoshima. 1980. Characterization of Y73, an avian sarcoma virus: a unique transforming gene and its product, a phosphopolyprotein with protein kinase activity. Proc. Natl. Acad. Sci. USA 77:6199–6203.
  • Kmiecik, T. E., P. J. Johnson, and D. Shalloway. 1988. Regulation by the autophosphorylation site in overexpressed pp60c-src. Mol. Cell. Biol. 88:4541–4546.
  • Kmiecik, T. E., and D. Shalloway. 1987. Activation and suppression of pp60c-src transforming ability by mutation of its primary sites of tyrosine phosphorylation. Cell 49:65–73.
  • Koeh, C. A., D. Anderson, Μ. F. Moran, C. Ellis, and T. Pawson. 1991. SH2 and SH3 domains: elements that control interactions of cytoplasmic signaling proteins. Science 252:668–674.
  • Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (London) 227:680–685.
  • Leslie, N. D., C. A. Kessler, S. Μ. Bell, and J. L. Degen. 1990. The chicken urokinase-type plasminogen activator gene. J. Biol. Chem. 265:1339–1344.
  • Li, P., K. Wood, H. Mammon, W. Haser, and T. Roberts. 1991. Raf-I : a kinase currently without a cause but not lacking in effects. Cell 64:479–482.
  • Lipsich, L. A., A. J. Lewis, and J. S. Brugge. 1983. Isolation of monoclonal antibodies that recognize the transforming proteins of avian sarcoma viruses. J. Virol. 48:352–360.
  • Lowenstein, E. J., R. J. Daly, A. G. Batzer, W. Li, B. Margolis, R. Lammers, A. Ulirich, E. Y. Skolnik, D. Bar-Sagi, and J. Schlessinger. 1992. The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling. Cell 70:431–442.
  • Maihle, N. J., and H. J. Kung. 1988. C-erbB and the epidermal growth-factor receptor: a molecule with dual identity. Biochim. Biophys. Acta 948:287–304.
  • Maihle, N. J., Μ. A. Raines, T. W. Fliekinger, and H. J. Kung. 1988. Proviral insertional activation of c-erb B: differential processing of the protein products arising from two alternate transcripts. Mol. Cell. Biol. 8:4868–4876.
  • Maki, Y., T. J. Bos, C. Davis, Μ. Starbuck, and P. K. Vogt. 1987. Avian sarcoma virus 17 carries the jun oncogene. Proc. Natl. Acad. Sci. USA 84:2848–2852.
  • Margolis, B., N. Li, A. Koch, Μ. Mohammadi, D. R. Hurwitz, A. Zilberstein, A. Ullrich, T. Pawson, and J. Schlessinger. 1990. The tyrosine phosphorylated carboxy terminus of the EGF receptor is a binding site for GAP and PLC-gamma. EMBO J. 9:4375–4380.
  • Matsuda, Μ., B. J. Mayer, Y. Fukui, and H. Hanafusa. 1990. Binding of transforming protein, P47gag-crk, to a broad range of phosphotyrosine-containing proteins. Science 248:1537–39.
  • Michel, D., G. Gillet, Μ. Volovitch, B. Pessac, G. Calothy, and G. Brun. 1989. Expression of a novel gene encoding a 51.5 kD precursor protein is induced by different retroviral oncogenes in quail neuroretinal cells. Oncogene Res. 4:127–136.
  • Milner, R. J., Μ. D. Brow, D. W. Cleveland, T. Μ. Shinnick, and J. G. Sutcliffe. 1983. Glyceraldehyde 3-phosphate dehydrogenase protein and mRNA are both differentially expressed in adult chickens but not chick embryos. Nucleic Acids Res. 11:3301–3315.
  • Moran, Μ. F., P. Polakis, F. McCormick, T. Pawson, and C. Ellis. 1991. Protein-tyrosine kinases regulate the phosphorylation, protein interactions, subcellular distribution, and activity of p21ras GTPase-activating protein. Mol. Cell. Biol. 11:1804–1812.
  • Morrison, D. K., D. R. Kaplan, U. Rapp, and T. Μ. Roberts. 1988. Signal transduction from membrane to cytoplasm: growth factors and membrane bound oncogene products increase Raf-I phosphorylation and associated protein kinase activity. Proc. Natl. Acad. Sci. USA 85:8855–8859.
  • Nori, M∙, U. S. Vogel, J. B. Gibbs, and Μ. J. Weber. 1991. Inhibition of v-src induced transformation by a GTPase-activating protein. Mol. Cell. Biol. 11:2812–2818.
  • Ossowski, L. 1988. Plasminogen activator dependent pathways in the dissemination of human tumor cells in the chick embryo. Cell 52:321–328.
  • Ossowski, L∙, and E. Reich. 1983. Antibodies to plasminogen activator inhibit human tumor metastasis. Cell 35:611–19.
  • Patschinsky, T., T. Hunter, and B. Μ. Sefton. 1986. Phosphorylation of the transforming protein of Rous sarcoma virus: direct demonstration of phosphorylation of serine 17 and identification of an additional site of tyrosine phosphorylation in p60v-src of Prague Rous sarcoma virus. J. Virol. 59:73–81.
  • Pawson, T., and G. D. Gish. 1992. SH2 and SH3 domains: from structure to function. Cell 71:359–362.
  • Potts, W. Μ., Μ. Olsen, D. Boettinger, and V. Μ. Vogt. 1987. Epitope mapping of monoclonal antibodies to gag protein pl9 of avian sarcoma and leukemia viruses. J. Gen. Virol. 68:3177–3182.
  • Purchio, A. F., Μ. Shoyab, and L. E. Gentry. 1985. Site-specific increased phosphorylation of pp60v-src after treatment of RSV- transformed cells with a tumor promoter. Science 229:1393–95.
  • Qureshi, S. A., K. Alexandropoulos, Μ. Rim, C. K. Joseph, J. T. Bruder, U. R. Rapp, and D. A. Foster. 1992. Evidence that Ha-Ras mediates two distinguishable intracellular signals activated by v-Src. J. Biol. Chem. 25:17635–17639.
  • Qureshi, S. A., X. Cao, V. P. Sukhatme, and D. A. Foster. 1991. v-Src activates mitogen-responsive transcription factor Egr-I via serum response elements. J. Biol. Chem. 266:10802–10806.
  • Roussel, Μ., S. Saule, C. Lagrou, C. Rommens, H. Beug, T. Graf, and D. Stehelin. 1979. Three new types of viral oncogene of cellular origin specific for haematopoietic cell transformation. Nature (London) 281:452–455.
  • Satoh, T., Μ. Nakafuku, and Y. Kaziro. 1992. Function of Ras as a molecular switch in signal transduction. J. Biol. Chem. 267:24149–24152.
  • Schonthal, A., P. Herrlich, H. J. Rahmsdorf, and H. Ponta. 1988. Requirement for fos gene expression in the transcriptional activation of collagenase by other oncogenes and phorbol esters. Cell 54:325–34.
  • Sheiness, D., L. Fanshier, and J. Μ. Bishop. 1978. Identification of nucleotide sequences which may encode the oncogenic capacity of avian retrovirus MC29. J. Virol. 28:600–610.
  • Simmons, D. L., D. B. Levy, Y. Yannoni, and R. L. Erikson. 1989. Identification of a phorbol ester-repressible v-src-induc- ible gene. Proc. Natl. Acad. Sci. USA 86:1178–1182.
  • Smart, J. E., H. Oppermann, A. P. Czernilofsky, A. F. Purchio, R. L. Erikson, and J. Μ. Bishop. 1981. Characterization of sites for tyrosine phosphorylation in the transforming protein of Rous sarcoma virus (pp60v-src) and its normal cellular homolog. Proc. Natl. Acad. Sci. USA 78:6013–6017.
  • Smith, Μ. R., S. J. DeGudicibus, and D. W. Stacey. 1986. Requirement for c-ras proteins during viral oncogene transformation. Nature (London) 320:540–543.
  • Snyder, Μ. A∙, and J. Μ. Bishop. 1984. A mutation at the major phosphotyrosine in pp60v-src alters oncogenic potential. Virology 136:375–386.
  • Snyder, Μ. A., J. Μ. Bishop, W. W. Colby, and A. D. Levinson. 1983. Phosphorylation of tyrosine-416 is not required for the transforming properties and kinase activity of pp60v-src. Cell 32:891–901.
  • Stacey, D. W., Μ. Roudebush, R. Day, S. D. Mosser, J. B. Gibbs, and L. A. Feig. 1991. Dominant inhibitory Ras mutants demonstrate the requirement for Ras activity in the action of tyrosine kinase oncogenes. Oncogene 6:2297–2304.
  • Sugano, S., Μ. Y. Stoeckle, and H. Hanafiisa. 1987. Transformation by Rous sarcoma virus induces a novel gene with homology to a mitogenic platelet protein. Cell 49:321–329.
  • Sullivan, L. Μ., and J. P. Quigley. 1986. An anticatalytic monoclonal antibody to avian plasminogen activator: its effect on behavior of RSV-transformed cells. Cell 45:905–915.
  • Tyagi, J. S., H. Hirano, and I. Pastan. 1985. Modulation of fibronectin gene activity in chick embryo fibroblasts transformed by a temperature-sensitive strain (ts68) of Rous sarcoma virus. Nucleic Acids Res. 13:8275–8284.
  • Unkeless, J. C., A. Tobia, L. Ossowski, J. P. Quigley, D. B. Rifken, and E. Reich. 1973. An enzymatic function associated with transformation of fibroblasts by oncogenic viruses. J. Exp. Med. 137:85–111.
  • Wang, H. C. R., and J. T. Parsons. 1989. Deletions and insertions within an amino-terminal domain of pp60v-src inactivate transformation and modulate membrane stability. J. Virol. 63:291–302.
  • Wasilenko, W. J., Μ. Nori, N. Testennan, and Μ. J. Weber. 1990. Inhibition of epidermal growth factor receptor biosynthesis caused by the src oncogene product, pp60v-src. Mol. Cell. Biol. 19:1254–1258.
  • Wilson, E. L., and E. Reich. 1978. Plasminogen activator in chick fibroblasts: induction of synthesis by retinoic acid; synergism with viral transformation and phorbol ester. Cell 15:385–392.
  • Wilson, E. L., and E. Reich. 1979. Modulation of plasminogen activator synthesis in chick embryo fibroblasts by cyclic nucleotides and phorbol myristate acetate. Cancer Res. 39:1579–1586.
  • Yaciuk, P., J. K. Choi, and D. ShaUoway. 1989. Mutation of amino acids in pp60c-src that are phosphorylated by protein kinases C and A. Mol. Cell. Biol. 9:2453–2463.
  • Yamamoto, T., H. Hihara, T. Nishida, S. Kawai, and K. Toyoshima. 1983. A new avian erythroblastosis virus, AEV-H, carries erbB gene responsible for the induction of both erythroblastosis and sarcomas. Cell 34:225–232.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.